Lemaitre Vascular, Inc.
A maker of medical devices for vascular surgery, headquartered outside Boston. Its products — including the UniFit graft and Valvulotome — help surgeons treat conditions like peripheral artery disease and maintain dialysis access, used by doctors in hospitals around the world. The company takes its name from its founder, George LeMaitre, a surgeon who built the business around devices he designed for the operating room.
Granted 1.29M · Bought 71.7K · Sold 3.69M
Granted 4.9K
Granted 4.9K
Granted 58.0K · Bought 41.2K · Sold 688.4K
Granted 9.9K · Sold 134.5K
Granted 42.0K · Sold 40.0K
Granted 106.4K · Bought 41.7K
Granted 27.4K
Granted 676.3K · Bought 2.0K · Sold 634.1K
Granted 575.3K · Bought 7.1K · Sold 813.3K
Granted 15.1K · Sold 1.5K
Granted 36.5K · Sold 32.5K
Granted 105.8K · Sold 101.7K
Granted 2.8K · Bought 4.0K
Granted 6.8K
Granted 6.2K
Granted 33.0K · Bought 1.3K · Sold 21.3K
Granted 5.6K
Granted 5.2K
Granted 45.9K · Bought 181 · Sold 30.0K
Granted 282.3K · Sold 262.9K
Granted 3.6K · Sold 2.3K
Granted 4.4K · Sold 1.5K
Granted 2.8K
Granted 2.8K
Granted 30.0K · Sold 30.0K
Granted 2.4K
Granted 605.7K · Sold 559.0K
Granted 35.0K · Sold 35.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| LeMaitre George WChairman and CEO, Director · 454 transactions | — | 2.93M | 1.29M | 71.7K | 3.69M |
| Housatonic Equity Investors LP/MaStockholder · 3 transactions | — | 1.39Mas of May 2010 | 4.9K | — | — |
| Jackson Michael CDirector · 3 transactions | — | 1.39Mas of May 2010 | 4.9K | — | — |
| LeMaitre Cornelia WDirector · 249 transactions | — | 784.4Kas of Aug 2016 | 58.0K | 41.2K | 688.4K |
| LeMaitre George DDirector · 29 transactions | — | 483.4Kas of Sep 2012 | 9.9K | — | 134.5K |
| Thorndike William N JrDirector · 17 transactions | — | 92.3Kas of May 2013 | 42.0K | — | 40.0K |
| O'Connor John JamesDirector · 73 transactions | — | 62.8K | 106.4K | 41.7K | — |
| Kelly Kevin DV. P. North American Sales · 7 transactions | — | 25.6Kas of Feb 2008 | 27.4K | — | — |
| Pellegrino Joseph P JRDirector · 224 transactions | — | 15.0K | 676.3K | 2.0K | 634.1K |
| Roberts David BPresident and Director, Director · 299 transactions | — | 14.7K | 575.3K | 7.1K | 813.3K |
| Grossman Aaron MVP & General Counsel · 18 transactions | — | 10.0Kas of Sep 2011 | 15.1K | — | 1.5K |
| Ross Bridget ADirector · 37 transactions | — | 9.0K | 36.5K | — | 32.5K |
| Jasinski Lawrence JDirector · 80 transactions | — | 7.8K | 105.8K | — | 101.7K |
| Gill David NDirector · 5 transactions | — | 6.8Kas of May 2007 | 2.8K | 4.0K | — |
| Cieslak Kimberly LVice President, Marketing · 2 transactions | — | 6.8Kas of Feb 2007 | 6.8K | — | — |
| Ngau Jonathan WV.P. Information Technology · 1 transaction | — | 6.2Kas of Dec 2006 | 6.2K | — | — |
| Linden Robert VSenior VP Sales, The Americas · 36 transactions | — | 5.7Kas of Jul 2014 | 33.0K | 1.3K | 21.3K |
| Helmers Maik DV.P. Central European Sales · 1 transaction | — | 5.6Kas of Dec 2006 | 5.6K | — | — |
| Connelly Ryan HDirector · 1 transaction | — | 5.2Kas of Dec 2006 | 5.2K | — | — |
| Roush John ADirector · 34 transactions | — | 4.3K | 45.9K | 181 | 30.0K |
| Kamke Trent GSenior V. P., Operations · 245 transactions | — | 3.7K | 282.3K | — | 262.9K |
| Wijas Michael TVP of Sales, The Americas · 3 transactions | — | 3.6Kas of Jun 2017 | 3.6K | — | 2.3K |
| Shadan MarthaDirector · 22 transactions | — | 3.0K | 4.4K | — | 1.5K |
| DeSisto Duane MDirector · 1 transaction | — | 2.8Kas of Dec 2006 | 2.8K | — | — |
| Neels Guido JDirector · 1 transaction | — | 2.8Kas of Dec 2006 | 2.8K | — | — |
| Hays Russell DDirector · 10 transactions | — | 2.5Kas of Mar 2014 | 30.0K | — | 30.0K |
| LeBlanc Dorian PaulChief Financial Officer · 4 transactions | — | 2.3K | 2.4K | — | — |
| Gebauer Peter RPresident, International OP · 211 transactions | — | 2.3Kas of Aug 2017 | 605.7K | — | 559.0K |
| Thomas Michael HDirector · 6 transactions | — | 0as of Aug 2019 | 35.0K | — | 35.0K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -6.91M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.